Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

PCSK9 Inhibitors in Clinical Practice

Citation:

US Cardiology Review 2017;11(2):105–9.

Novel Treatments for Cardiovascular Disease

Citation:

US Cardiology Review 2017;11(2):98–104.

Appropriate Use Criteria and the Imaging Mandate

Citation:

US Cardiology Review 2018;12(1):36–40.

Influence of Race in the Association of Diabetes and Heart Failure

Citation:

US Cardiology Review 2018;12(1):17–21.